According to a new market report published by Lucintel, the future of the pharmacokinetic service market looks promising with opportunities in the hospitals and pharmaceutical companies. The global pharmacokinetic service market is expected to grow with a CAGR of 8% from 2020 to 2025. The major drivers for this market are to reduce concerns about high drug attrition and enable early identification of potential challenge.
To download report brochure, please go to https://www.lucintel.com/pharmacokinetic-service-market.aspx and click "download brochure" tab from the menu
Pharmacokinetics (PK) refers to the movement of drugs through the body. In this market, small molecules pharmacokinetic services and large molecules (biopharmaceuticals) pharmacokinetic services are the major drug types. Lucintel forecasts that small molecule pharmacokinetic services will remain the largest drug type segment over the forecast period due to increasing emphasize on studying molecules of smaller atomic weight and drug metabolism.
North America will remain the largest region, and it is also expected to witness the highest growth over the forecast period due to the presence of a large number prominent pharmaceutical companies in the region and presence of effective regulatory structure pertaining to drug development processes including PKPD (pharmacokinetic and pharmacodynamic determinant) and toxicology studies in the region.
Evotec, Certara, Pacific BioLab, GVK Biosciences, Shanghai Medicilon, Pharmaceutical Product Development, Charles River Laboratories International, PAREXEL International Corporation, Eurofins Scientific, and Frontage Labs are among the major suppliers in the global pharmacokinetic service market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global pharmacokinetic service market by drug type, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Pharmacokinetic service Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global pharmacokinetic service market by drug type, end user, and region as follows:
By Drug Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Small Molecule Pharmacokinetic services
Large Molecule (Biopharmaceutical) Pharmacokinetic Services
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals
Pharmaceutical Companies
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.